BY KENNETH MENDEZ & JC SCOTT During the early stages of the COVID-19 pandemic in the United States, people with chronic health conditions like asthma, unfortunately, experienced some shortages on their medications.
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Administration’s announcement on 2021 Medicare Part D premiums. “PCMA applauds the Administration for its work continuing the success of the Part D
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing the launch of a TV and digital advertising campaign on President Trump’s Executive Order to revive the so-called rebate rule. The campaign warns policymakers and the public that the
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Administration’s Executive Order to resurrect the rebate rule. “The Administration’s decision last year to withdraw a proposed regulation on prescription drug
The vast majority of employers say PBMs are effective at reducing drug costs for their organizations.
JC Scott speaks with Doug Long, Vice President of Industry Relations at IQVIA, about the impact of COVID-19 on the pharmaceutical market. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare
Our national survey of benefit managers and human resources directors, conducted online June 4-9, 2020, consists of 250 respondents drawn from a list of benefit managers and human resources directors provided by Dynata. All respondents work for a company with
(Washington, D.C.) — As employers confront a challenging economic environment and are examining options to both reduce costs and improve health care quality for workers, a national survey of benefit managers and human resources directors from North Star Opinion Research
©2024 PCMA. All Rights Reserved.
